Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is experiencing a temporary decline in its stock due to raised expectations for its Home and Women's Health division and a weaker 2Q EBITDA forecast. However, management is confident in a potential 2H ramp up, and the company's 2026 guidance has been reduced marginally but still expects strong revenue and earnings growth. It is difficult for the company to maintain this level of growth without competitive exits or procurement benefits in other drug categories, leading to potential downside risk.

Bears say

Option Care Health is facing significant challenges such as unexpected headwinds in certain therapies, weaker-than-expected performance in lower-margin therapies, and declines in revenue and cash generation as reflected in its recent mixed-bag first quarter results and updated financial guidance. The company's 2026 financial targets may be perceived as aggressive by investors with its assumption of significant growth in the second half of 2026, leading to a significant share price decline. It is also important to note that materiality can vary between sectors and over time, making it difficult to accurately assess the company's ESG performance.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.